The Experimental Study of 32 P and Diallyl Trisulfide Coating Stent for Inhibiting Neoinfimal Hyperplasia in a Canine Model of Coronary Restenosis

徐尚华,江洪,李庚山,吴可贵,蒋学俊,李晓艳,陈元秀,王海蓉,聂晓敏
DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2004.03.012
2004-01-01
Abstract:Objective To asesses the efficiency of 32 P and diallyl trisulfide (DT)-coated coronary stents on neointimal proliferation in a canine model of restenosis. Methods 32 P (740 kBq/stent), DT (210 μg/stent) alone and jointly coated stents were deployed with mild oversizing in both the left circumflex coronary artery (LCX) and the left anterior descending coronary artery (LAD) of 10 dogs. The implantation of protein-coated stents was used as the control. The therapeutic effect was assessed 6 months after the intervention. The dogs were sacrificed and the vessels were excised. For morphologic examinations the tissue sections were stained with HE and Van Gieson. Results Compared with the control stents, the neointimal area reduced in stents coated with 32 P, DT alone and 32 P+DT [ 32 P:(2.63±0.48)mm 2, DT:(2.50±0.49)mm 2, 32 P+DT:(1.42±0.41)mm 2 vs control group:(4.87±0.80)mm 2, P=0.001]. 32 P+DT was more effective than either of them alone for reducing the neointimal area (P≤0.005). Both jointly and alone coated stents of 32 P, DT decreased the percent area stenosis [ 32 P:(32.48±4.79 )%, DT: (30.04±5.43)%, 32 P+DT: (17.21±4.05)% vs control group:(54.62±6.82)%, P0.001], whereas the percent area stenosis was significantly smaller in 32 P+ DT group compared with 32 P or DT-coated stents group (P≤0.001). Angiographic restenosis (diameter stenosis) was lighter in stents coated with 32 P, DT and 32 P+DT compared with control stents (P0.001). 32 P+DT was more effective than 32 P or DT alone for reducing diameter stenosis (P≤0.005). No evidence of ‘edge effect’ was seen in adjacent, nonstented coronary segments. Conclusion Coronary stents coated with 32 P plus DT produced a significantly reduced neointimal hyperplasia and restenosis rate in the canine LCX and LAD 6 months after stents implantation.
What problem does this paper attempt to address?